The role of inflammation as a pathogenic factor in the development of renal disease in diabetes

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Current Diabetes Reports

• Publication date

  2005-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/S11892-005-0044-XPMID 16316588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy.

  2005cited by this paper
• Comparison of the Effect of Pentoxifylline and Captopril on Proteinuria in Patients with Type 2 Diabetes mellitus

  2005cited by this paper
• Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial.

  2005cited by this paper
• Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes.

  2005cited by this paper
• Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.

  2005cited by this paper
• Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice.

  2005cited by this paper
• Pentoxifylline Ameliorates Renal Tumor Necrosis Factor Expression, Sodium Retention, and Renal Hypertrophy in Diabetic Rats

  2004cited by this paper
• Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.

  2004cited by this paper
• Type 2 diabetes mellitus: a disease of the innate immune system? An update

  2004influential reference
• A central role for inflammation in the pathogenesis of diabetic retinopathy

  2004cited by this paper
• Combination of Pentoxifylline with Angiotensin Converting Enzyme Inhibitors Produces an Additional Reduction in Microalbuminuria in Hypertensive Type 2 Diabetic Patients

  2003cited by this paper
• Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study.

  2003cited by this paper
• Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes.

  2003cited by this paper
• Role of Neuropoietic Cytokines in Development and Progression of Diabetic Polyneuropathy: From Glucose Metabolism to Neurodegeneration

  2003cited by this paper
• Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats.

  2003cited by this paper
• Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus.

  2003cited by this paper
• Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

  2000cited by this paper
• Association between C-reactive protein and features of the metabolic syndrome: a population-based study.

  2000cited by this paper
• Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration.

  1999cited by this paper
• End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.

  1999cited by this paper
• TNF-alpha increases albumin permeability of isolated rat glomeruli through the generation of superoxide.

  1998cited by this paper
• Is Type II diabetes mellitus a disease of the innate immune system?

  1998cited by this paper
• Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients.

  1995cited by this paper
• Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy.

  1991cited by this paper
• Pentoxifylline suppression of tumor necrosis factor gene transcription.

  1991cited by this paper
• Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

  1990cited by this paper
• Biological and clinical aspects of interleukin 6.

  1990cited by this paper
• Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells.

  1989cited by this paper
• Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability.

  1989cited by this paper
• Mesangial cells, effect of monocyte products on proliferation and matrix synthesis.

  1982cited by this paper

• Effects of acteoside on the expressions of MCP-1 and TGF-β1 in the diabetic nephropathy mice

  2022influential citation
• The Relationship Between Metabolic Parameters, Age, and Thyroid Status: A Cross-Sectional Study-Based National Survey of Iodine Nutrition, Thyroid Disease

  2021cites this paper
• RMHP_A_306122 1723..1730

  2021cites this paper
• MG132 protects against renal dysfunction by regulating Akt-mediated inflammation in diabetic nephropathy

  2019cites this paper
• Podoplanin mediates the renoprotective effect of berberine on diabetic kidney disease in mice

  2019cites this paper
• Association of urinary monocyte chemoattractant protein-1 (MCP-1) and kidney injury molecule-1 (KIM-1) with risk factors of diabetic kidney disease in type 2 diabetes patients

  2019cites this paper
• Different Doses of Tripterygium Glycosides in the Treatment of Diabetic Nephropathy: Effects on Blood Lipids

  2018cites this paper
• Exploring macrophage cell therapy on Diabetic Kidney Disease

  2018influential citation
• Interleukin 10 Gene Polymorphisms and Susceptibility to Nephropathy in Egyptian Diabetic Patients

  2017cites this paper
• Effects of 1, 25-dihydroxyvitamin D3 on expression of TGF-β1, CD68 and MCP-1 in type 2 diabetic nephropathy rat

  2017cites this paper
• Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus

  2016cites this paper
• Effects of Triptergium Glycosides on Expressions of MCP- 1 and CTGF in Rats with Early Diabetic Nephropathy

  2016cites this paper
• Aggravating role of inflammation in diabetic kidney disease

  2016influential citation
• Fenofibrate attenuates diabetic nephropathy in experimental diabetic rat's model via suppression of augmented TGF-β1/Smad3 signaling pathway

  2016cites this paper
• Timosaponin B-ii ameliorates diabetic nephropathy via TXniP, mTOr, and nF- κ B signaling pathways in alloxan-induced mice

  2015cites this paper
• Timosaponin B-ii ameliorates diabetic nephropathy via TXniP, mTOr, and nF- κ B signaling pathways in alloxan-induced mice

  2015cites this paper
• Timosaponin B-II ameliorates diabetic nephropathy via TXNIP, mTOR, and NF-κB signaling pathways in alloxan-induced mice

  2015cites this paper
• Interleukin-10-1082A/G Polymorphism and Diabetic Nephropathy: A Meta-Analysis

  2015cites this paper
• Timosaponin B-ii ameliorates diabetic nephropathy via TXniP, mTOr, and nF- κ B signaling pathways in alloxan-induced mice

  2015cites this paper
• The Influence of Corn Silk Polysaccharide on Signal Pathway of TGF-β1 in Type 2 Diabetic Mellitus Rat

  2015cites this paper
• Value of Urinary Cystatin C In Early Detection Of Diabeticnephropathy In Type 2 Diabetes Mellitus

  2015cites this paper
• Investigation on the association between inerleukin-10 -592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephrophathy.

  2015cites this paper
• Timosaponin B-ii ameliorates diabetic nephropathy via TXniP, mTOr, and nF- κ B signaling pathways in alloxan-induced mice

  2015cites this paper
• Protective role of oryeongsan against renal inflammation and glomerulosclerosis in db/db mice.

  2014cites this paper
• Effects of triptergium glycosides on the expression of MCP-1 and CTGF in rats with early diabetic nephropathy

  2014cites this paper
• Effects of total glucosides of paeony on immune regulatory toll-like receptors TLR2 and 4 in the kidney from diabetic rats.

  2014cites this paper
• Association of biomarkers of inflammation and oxidative stress with the risk of chronic kidney disease in Type 2 diabetes mellitus in North Indian population.

  2013cites this paper
• Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats

  2013cites this paper
• Total and differential leukocytes count in type 2 diabetes mellitus patients in Iraq

  2012cites this paper
• Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells.

  2012cites this paper
• Fibrates: therapeutic potential for diabetic nephropathy?

  2012cites this paper
• Knockout of Toll-Like Receptor-2 Attenuates Both the Proinflammatory State of Diabetes and Incipient Diabetic Nephropathy

  2011cites this paper
• An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes.

  2011cites this paper
• Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway.

  2011cites this paper
• Correlation Between Tumor Necrosis Factor Alpha and Proteinuria in Type-2 Diabetic Patients

  2010cites this paper
• Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.

  2010cites this paper
• Cardiovascular , Pulmonary and Renal Pathology Late Onset of Ccl 2 Blockade with the Spiegelmer mNOX-E 36 – 3 PEG Prevents Glomerulosclerosis and Improves Glomerular Filtration Rate in db / db Mice

  2010cites this paper
• Intensive insulin therapy reduces the urinary intercellular adhesion molecule-1 excretion in patients with Type 2 diabetes mellitus

  2009cites this paper
• Interleukin‐10–592C/A, –819C/T and –1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients

  2009cites this paper
• Changes of serum and urine neutrophil gelatinase-associated lipocalin in type-2 diabetic patients with nephropathy: one year observational follow-up study

  2009cites this paper
• Renoprotective effect of total glucosides of paeony (TGP) and its mechanism in experimental diabetes.

  2009cites this paper
• Predictive value of interleukin‐10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients

  2009cites this paper
• Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy.

  2009cites this paper
• DISEASE AMONG WOMEN IN MENOPAUSAL TRANSITION

  2008cites this paper
• Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice.

  2008cites this paper
• FAT PARTITIONING AND SUBCLINICAL CARDIOVASCULAR DISEASE AMONG WOMEN IN MENOPAUSAL TRANSITION

  2008cites this paper
• The role of chemokine receptor CCR1-dependent macrophage recruitment for the progression of chronic kidney disease in murine Alport syndrome or type 2 diabetes

  2008cites this paper
• Nephrin and podocin loss is prevented by mycophenolate mofetil in early experimental diabetic nephropathy.

  2008cites this paper
• The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice.

  2007cites this paper
• Renal Pro-Inflammatory Cytokine Gene Expression in Diabetic Nephropathy: Effect of Angiotensin-Converting Enzyme Inhibition and Pentoxifylline Administration

  2007cites this paper
• Telmisartan, an Angiotensin II Type 1 Receptor Blocker, Inhibits Advanced Glycation End-product (AGE)-induced Monocyte Chemoattractant Protein-1 Expression in Mesangial Cells through Downregulation of Receptor for AGEs via Peroxisome Proliferator-activated Receptor-γ Activation

  2007cites this paper
• Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation.

  2007cites this paper
• Nifedipine, a Calcium-channel Blocker, Inhibits Advanced Glycation End-product-induced Expression of Monocyte Chemoattractant Protein-1 in Human Cultured Mesangial Cells

  2007cites this paper
• Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.

  2006cites this paper